跳至主要内容
临床试验/NCT01246336
NCT01246336已完成不适用

Exploratory Study to Detect Volatile Biomarkers of Idiopathic Parkinson's Disease and Parkinsonism From Exhaled Breath Using a Nanomedical Artificial Olfactory System.

Rambam Health Care Campus0 个研究点目标入组 41 人开始时间: 2009年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
41
主要终点
Nanosensory detection

研究概览

简要总结

Parkinson's disease is diagnosed clinically, because biomarkers that may help in diagnosis and differential diagnosis are not yet available. Exhaled breath testing may yield a "breath-print" that can be used to distinguish healthy and diseased states.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Parkinsonism

排除标准

  • Severe dementia

结局指标

主要结局

Nanosensory detection

时间窗: immediate

analyze combinations of nanomaterial-based sensors (organically functionalized carbon nanotubes and gold nanoparticles)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ilana Schlesinger

Ilana Schleainger, Rambam Health Care Campus

Rambam Health Care Campus

相似试验

Exploratory Study Using Nanotechnology to Detect... | 临床试验